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Disrupted circadian oscillations in type 2 diabetes are 
linked to altered rhythmic mitochondrial metabolism 
in skeletal muscle
Brendan M. Gabriel1,2†, Ali Altıntaş3†, Jonathon A. B. Smith1, Laura Sardon-Puig4, Xiping Zhang5, 
Astrid L. Basse3, Rhianna C. Laker3, Hui Gao6, Zhengye Liu7, Lucile Dollet1, Jonas T. Treebak3, 
Antonio Zorzano8,9,10, Zhiguang Huo11, Mikael Rydén12, Johanna T. Lanner7, Karyn A. Esser5, 
Romain Barrès3, Nicolas J. Pillon1, Anna Krook1, Juleen R. Zierath1,3,4*‡
Circadian rhythms are generated by an autoregulatory feedback loop of transcriptional activators and repressors. 
Circadian rhythm disruption contributes to type 2 diabetes (T2D) pathogenesis. We elucidated whether altered 
circadian rhythmicity of clock genes is associated with metabolic dysfunction in T2D. Transcriptional cycling of 
core-clock genes BMAL1, CLOCK, and PER3 was altered in skeletal muscle from individuals with T2D, and this was 
coupled with reduced number and amplitude of cycling genes and disturbed circadian oxygen consumption. 
Inner mitochondria–associated genes were enriched for rhythmic peaks in normal glucose tolerance, but not T2D, 
and positively correlated with insulin sensitivity. Chromatin immunoprecipitation sequencing identified CLOCK 
and BMAL1 binding to inner-mitochondrial genes associated with insulin sensitivity, implicating regulation by 
the core clock. Inner-mitochondria disruption altered core-clock gene expression and free-radical production, 
phenomena that were restored by resveratrol treatment. We identify bidirectional communication between mito-
chondrial function and rhythmic gene expression, processes that are disturbed in diabetes.
INTRODUCTION
Type 2 diabetes (T2D) is a growing global health problem, with 
skeletal muscle insulin resistance being a primary defect in the pa-
thology of this disease. While the etiology of this disease is complex, 
perturbed sleep/wake rhythms from shift-work, sleep disorders, and 
social jet lag are associated with obesity, T2D, and related comor-
bidities (1–4), highlighting the critical role of the circadian timing 
system for metabolic health. Cell autonomous circadian rhythms are 
generated by a transcription-translation autoregulatory feedback 
loop composed of transcriptional activators CLOCK and BMAL1 
(ARNTL) and their target genes Period (PER), Cryptochrome (CRY), 
and REV-ERB (NR1D1), which rhythmically accumulate and form 
a repressor complex that interacts with CLOCK and BMAL1 to in-
hibit transcription (5). Disruption of the molecular clock in skeletal 
muscle leads to obesity and insulin resistance in mouse models (6–8). 
While disrupted circadian rhythms alter metabolism, the extent to 
which these processes are impaired in people with T2D is unknown.
Several lines of evidence suggest that the link between dysregu-
lated molecular-clock activity and T2D or insulin resistance may be 
tissue dependent. In white adipose tissue, the evidence is equivocal. 
For example, subcutaneous white adipose tissue biopsies showed no 
difference of rhythm and amplitude of core-clock (PER1, PER2, PER3, 
CRY2, BMAL1, and DBP), clock-related (REVERB), and metabolic 
(PGC1) genes between individuals with normal weight, obesity, or 
T2D over a time-course experiment (9). Conversely, when the sleep/
wake cycle and dietary regime are controlled, amplitude oscillations 
of core-clock genes and number of rhythmic genes are reduced in adipose 
tissue from people with T2D as compared with healthy, lean individuals 
(10). In human leukocytes collected over a time-course experiment, 
mRNA expression of BMAL1, PER1, PER2, and PER3 was lower in 
people with T2D as compared to nondiabetic individuals (11). In addi-
tion, BMAL1, PER1, and PER3 mRNA expression in leukocytes col-
lected from people with T2D is inversely correlated with hemoglobin A1C 
(HbA1c) levels, suggesting an association of molecular-clock gene ex-
pression with T2D and insulin resistance. Furthermore, in pancreatic 
islets from individuals with T2D or healthy controls, PER2, PER3, and 
CRY2 mRNA expression is positively correlated with islet insulin 
content and plasma HbA1c levels (12). Thus, there may be tissue speci-
ficity of molecular-clock regulation, which contributes to clinical out-
comes related to insulin sensitivity and T2D etiology. The underlying 
mechanisms regulating metabolic rhythmicity and, particularly, 
whether rhythmicity is lost in T2D remain incompletely understood.
At the cellular level, primary human myotubes maintain a circadian 
rhythm, with the amplitude of the circadian gene REV-ERB cor-
relating with the metabolic disease state of the donor groups (13). 
This apparent link between the skeletal muscle molecular clock and 
insulin sensitivity may be partly mediated by molecular-clock regulation 
of metabolic targets. Chromatin immunoprecipitation (ChIP) 
sequencing has revealed distinct skeletal muscle–specific BMAL1 
and REV-ERB cistromes (14), with prominent molecular 
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clock–targeted pathways, including mitochondrial function and 
glucose/lipid/protein metabolism (14, 15). Moreover, these meta-
bolic pathways may participate in retrograde signaling to control 
aspects of the molecular clock. Pharmacological inhibition of DRP1, 
a key regulator of mitochondrial fission and metabolism, alters the 
period length of BMAL1 transcriptional activity in human fibro-
blasts (16). However, the signals and the clock-derived alterations that 
govern the rhythmicity of metabolism remain incompletely under-
stood. Despite the growing evidence that several metabolic pathways are 
under circadian control, it is not clear whether circadian rhythmicity of 
the intrinsic molecular clock is altered in T2D. Here, we determined 
whether circadian control of gene expression and metabolism is altered 
at the cellular level in skeletal muscle from individuals with T2D.
RESULTS
Intrinsically dysregulated circadian rhythm of gene 
expression in T2D
Skeletal muscle biopsies were obtained from men with either T2D 
or normal glucose tolerance (NGT) (Fig.  1A). Primary myotube 
cultures were prepared, synchronized, and harvested every 6 hours 
over 42 hours, and the transcriptome was analyzed by RNA se-
quencing. To determine whether genes displayed a rhythmic cycle 
over 24 hours, we analyzed the RNA-sequencing expression values 
using “rhythmicity analysis incorporating non-parametric methods” 
(RAIN) algorithm with longitudinal method (table S1) (17). Myo-
tubes from T2D donors displayed fewer cycling rhythmic genes as 
compared to myotubes from NGT donors. The rhythmic genes in 
NGT were also significantly associated with the rhythmic genes in 
T2D as the overlap between NGT and T2D circadian genes was sig-
nificant with an odds ratio (OR) greater than 1 (Fig.  1B, Fisher’s 
exact test, OR = 2.56, P = 1.74 ×10−60). To induce acute insulin re-
sistance and partly mimic a T2D milieu (18), myotubes from NGT 
and T2D donors were treated with high glucose and insulin (50 nM 
insulin and 25 mM glucose) for 24 hours before serum shock. Treatment 
with a high concentration of glucose and insulin reduced the number 
of cycling genes in myotubes from both T2D (−868 genes, 56.4% 
reduction) and NGT (−2378 genes, 57.9% reduction) donors (Fig. 1C). 
We performed Gene Set Enrichment Analysis (GSEA) and found that 
the Reactome pathway (Fig. 1D) (19) “Circadian Clock” was enriched 
in all conditions. To assess the altered rhythmicity (the so-called dif-
ferential rhythmicity) between NGT and T2D, the RNA- sequencing 
expression values from the NGT and T2D donors were compared 
to each other using an algorithm for detection of differential rhyth-
micity (DODR) (17). PER3 and BMAL1 (aka ARNTL) were differen-
tially rhythmic between NGT and T2D donors (in total, six genes 
were shown to be differentially rhythmic between NGT and T2D donors; 
table S2) [Fig. 1E; both genes false discovery rate (FDR)DODR = 0.094]. 
The molecular-clock gene CLOCK was exclusively cycling in NGT do-
nors (FDRRAIN < 0.1) (Fig. 1E). These results indicate that myotubes 
from the NGT donors had more genes displaying rhythmic behavior. 
In addition, two (BMAL1 and PER3) core-clock genes displayed differential 
rhythmicity (DODR) and one (CLOCK) was exclusively rhythmic 
(RAIN) in myotubes from NGT and T2D donors.
Reduced amplitudes of rhythmic gene expression in T2D
An important factor that is often physiologically relevant in circadian 
and diurnal biology is the magnitude of cycling peaks and nadirs 
over the course of a cycle, which can be quantified by measuring the 
amplitude of cycling patterns. We used harmonic regression to de-
termine relative amplitude of cycling gene expression in myotubes 
from NGT and T2D donors within the RNA-sequencing dataset 
(table S3). The log2 relative amplitudes of the circadian genes (T2D 
compared to NGT) were significantly different from noncircadian 
genes (Fig. 2A; P < 2.2 × 10−16, two-sided Kolmogorov-Smirnov test), 
and the mean relative amplitude of cycling genes was lower in T2D 
as compared to NGT (Fig.  2B; P  <  2.2 × 10−16, paired two-sided 
Wilcoxon rank sum test). Furthermore, we created heatmaps to better 
visualize the differences in amplitudes between NGT and T2D groups 
(Fig. 2C). These heatmaps demonstrated that although most cycling 
genes had reduced cycling amplitudes in T2D, there were also several 
that displayed higher amplitudes in T2D compared to NGT.
Altered peak-time signature of cycling inner-mitochondrial 
genes and ablated rhythmic mitochondrial metabolism 
in myotubes from T2D donors
Analyzing the same RNA-sequencing data as described in Fig. 1, we 
used the RAIN algorithm to determine the peak time of the cycling 
genes in the myotube cultures. T2D displayed an altered pattern of 
cycling gene peaks as compared to NGT (Fig. 3, A and B). In per-
centage terms, T2D had the highest number of cycling genes displaying 
peaks at 24 hours, whereas NGT had the highest number of cycling 
genes displaying peaks at 12 hours (Fig. 3B). When myotubes were treated 
with a high concentration of glucose and insulin (Fig. 3, C and D), 
the peak at which T2D had the largest amount of cycling genes re-
mained consistent (24 hours), while the highest peak genes in NGT 
was shifted to 24 hours. When considering the molecular-clock genes 
and clock-output genes (Fig. 3E), NPAS2 displayed different peak times 
between NGT [Zeitgeber time, 18 hours (ZT18)] and T2D (ZT12).
We then performed a gene enrichment analysis [over-representation 
analysis (ORA)] for each condition and gene peak time. Several mito-
chondrial Gene Ontology (GO) cellular components (CC) (“mitochondrial 
matrix,” “mitochondrial inner membrane,” and “mitochondrial protein 
complex”) displayed enrichment for cycling genes at peak time 24 hours 
(ZT24) in NGT but not in any other condition (Fig. 3F). Genes displaying 
peak times at ZT24 in cells from NGT donors were also associated with 
the Reactome pathway (histone acetyltransferase) “HATs acetylate 
histones” (fig. S3).
Given that an absence of mitochondrial GO:CC at ZT24 was 
observed in myotubes from the T2D donors (Fig. 3F) and that T2D 
is associated with reduced skeletal muscle mitochondrial function and 
metabolic inflexibility (20), we investigated whether synchronized 
myotubes from NGT and T2D donors displayed circadian oscilla-
tions of oxygen consumption rate (OCR, a proxy for mitochondrial 
metabolism; Fig.  3G). We observed differential rhythmicity of 
OCR between NGT and T2D (DODR, FDR = 4.08 × 10−9) (Fig. 3H). NGT 
displayed cycling OCR with a 16-hour period (FDRRAIN = 0.015), 
whereas T2D did not (or any other period). In addition, we per-
formed a separate Mito Stress Test at a single time point (ZT24) 
after serum shock (fig. S4). In this assay, mitochondrial function did 
not differ between the myotubes from NGT and T2D donors. Thus, 
the difference of rhythmic mitochondrial function between the 
myotubes from the NGT and T2D donors may be derived from 
temporal regulation of oxygen consumption rather than differences 
in mitochondrial function per se. Overall, our data (Fig. 3) demon-
strate that myotubes from T2D donors have reduced mitochondrial 
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Mitochondrial inner membrane is enriched for genes that 
correlate with whole-body insulin sensitivity
To test the in vivo clinical relevance of our findings in the primary 
myotube cultures, we performed a transcriptomic analysis on vas-
tus lateralis muscle biopsies obtained from men with NGT (n = 24) 
or T2D (n = 25) at a single time point (Fig. 4A). In addition, a 
hyperinsulinemic-euglycemic clamp was performed to determine 
whole-body insulin sensitivity (M value, analysis pipeline shown in 
Fig. 4A). As expected, insulin sensitivity was greater in men with 
NGT as compared to those with T2D (Fig. 4B, P < 0.0001). The 
relationship between basal skeletal muscle gene expression and in-
sulin sensitivity across the whole cohort was assessed by Spearman’s 
rank correlation (Fig. 4A). A gene enrichment analysis (ORA) with 
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Fig. 1. Intrinsically dysregulated circadian rhythm of gene expression in T2D. (A) Schematic overview of primary cell culture circadian experiment and RNA sequencing. 
RNA sequencing of primary human skeletal muscle cells from men with NGT (n = 7) or T2D (n = 5). (B) Venn diagram showing the overlapping rhythmic genes between 
NGT and T2D. Overlapping rhythmic genes were significantly enriched (Fisher’s exact test, P = 1.74 × 10−60; odds ratio, OR = 2.56, background = 18,482). (C) Upset plot 
showing number of circadian genes identified via RAIN analysis for each disease and treatment comparison (FDR < 0.10). (D) Circadian gene enrichment results using ORA 
(Fisher’s exact test) and Reactome pathways. Circadian genes identified via RAIN analysis (FDR < 0.10), and the top 10 enriched Reactome pathways are shown (FDR < 0.10). 
(E) Circadian rhythmicity of core clock genes. Red = T2D, black = NGT. Lines show the harmonic regression fits and solid line indicates circadian (FDR < 0.10) genes, while 
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correlating (Spearman’s rank correlation) with basal gene expression. 
We found that most of the enriched GO:CC were related to the mito-
chondria (FDR < 0.10; Fig. 4, C and D). The GO:CC “mitochondrial 
matrix” and “mitochondrial inner membrane” were enriched at ZT24 in 
myotubes from NGT donors (Figs. 3F and 4D). Our analysis points 
at the inner mitochondria as a cellular location implicated in the 
regulation of skeletal muscle insulin sensitivity in vivo, as well as the 
impaired cycling behaviors in skeletal myotubes from T2D donors.
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Fig. 2. Reduced amplitudes of overall rhythmic gene expression in T2D. (A) Log2 relative amplitude of circadian genes for T2D as compared to NGT; relative ampli-
tudes were determined via harmonic regression with first-degree polynomial trend using mean-centered data. Histogram of circadian genes (red) and all genes (black), 
log2 relative amplitude of T2D versus NGT. The main panel shows count histogram of log2 relative amplitudes of circadian genes (red) and noncircadian genes (black). 
Right panels show the density distributions and empirical cumulative distribution function. Red = circadian, determined via RAIN algorithm (FDR < 0.1), black = noncircadian. 
Log2 relative amplitude distributions were significantly different in circadian genes compared to noncircadian genes (PKS < 2.2 × 10−16, two-sided Kolmogorov-Smirnov 
test).  = population mean. (B) Boxplots showing the relative amplitude comparison between NGT and T2D groups for the union of circadian genes. Means and medians 
are reported for each group in the plot. Black: NGT, red: T2D groups. The difference between the relative amplitudes are calculated using Wilcoxon rank sum test (****P < 2.2 × 
10−16). (C) Heatmaps showing the amplitude differences of RNA-sequencing gene expression data of NGT and T2D groups. The linear trends are removed for visual pur-
poses to highlight the patterns in data (see Materials and Methods). To show the amplitude differences between NGT and T2D, the data were mean-centered for the 
groups. Each time point shown in the heatmap is the average value after mean-centering. Hierarchical clustering was performed by using geodesic distance and “ward.
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Fig. 3. Altered peak-time signature of cycling inner-mitochondrial genes and ablated rhythmic mitochondrial metabolism in myotubes from T2D donors. 
(A) Number of circadian genes at each peak time for control treatments. (B) Percentage of circadian genes at each peak time for control treatments. (C) Number of circadian 
genes at each peak time when treated with high concentrations of glucose and insulin. (D) Percentage of circadian genes at each peak time when treated with high 
concentrations of glucose and insulin. (E) Heatmap showing the peak times of core clock genes for control conditions and cells treated with high concentrations of glu-
cose and insulin. Colors represent the peak times. Hierarchical clustering was performed by using geodesic distance and “ward.D2” algorithm. Asterisks represent the 
adjusted P values from rhythmicity analysis (RAIN): ***0 ≤ P ≤ 0.001; **0.001 < P ≤ 0.01; *0.01 < P ≤ 0.05; ⋅ 0.05 < P ≤ 0.1; empty boxes, 0.1 < P ≤ 1. (F) GO:CC enriched at each 
time point in NGT (control), T2D (control), NGT (high concentration of glucose and insulin), and T2D (high concentration of glucose and insulin). (G) Schematic of circadian 
basal cellular oxygen consumption rate (OCR) time-course experiment. (H) Relative OCR of synchronized myotube cultures from donors with NGT (black) versus T2D (red), 
as measured by Seahorse XF Analyzer (Agilent) for n = 5 donors in each group. Differential rhythmicity (DODR, period = 16 hours) and rhythmicity (RAIN) analysis statistics 
are shown in table inset. See also fig. S4. Lines show the harmonic regression fits, and solid line indicates rhythmic (FDRRAIN < 0.1) OCR, while dashed lines indicate 
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Mitochondrial pathways are enriched for genes with CLOCK 
and BMAL1 binding and are associated with whole-body 
insulin sensitivity
In the current study, we describe intrinsically dysregulated rhythm, 
peak time, and amplitudes of cycling genes in myotubes from T2D 
as compared to NGT donors. We also observed impaired cycling 
behavior of mitochondrial-related genes in T2D, coupled with 
functionally dysregulated mitochondrial rhythmic metabolism. How-
ever, the regulatory directionality of these phenomena (i.e., rhythmic 
dysfunction of the molecular-clock and mitochondrial metabolism) 
is unclear. Whether both BMAL1 and CLOCK partially regulate 
mitochondrial metabolism in skeletal muscle is also unclear. We 
found that these molecular-clock genes were rhythmically dysregulated 
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Fig. 4. Mitochondrial inner membrane is enriched for genes that correlate with whole-body insulin sensitivity. (A) Schematic of experimental design. (B) Insulin 
sensitivity (M value: mg glucose infused/kg per minute) of T2D and NGT participants. Student’s t test. (C) Enrichment analysis based on microarray of skeletal muscle 
biopsies obtained in the fasted state from 24 men with NGT and 25 men with T2D. Top 10 differentially enriched GO:CC, ranked by gene ratios (FDR < 0.10). Pathway en-
richment calculated from genes correlating (FDR < 0.10) with M value (whole-body insulin sensitivity) in vivo. (D) GO term–gene interaction plot of the top five GO:CC 
enrichments calculated from genes correlating (FDR < 0.1) M value (whole-body insulin sensitivity) in vivo: organelle inner membrane, mitochondrial inner membrane, 
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tested whether BMAL1 and CLOCK binding was associated with 
mitochondrial genes involved in insulin sensitivity and dysregulated 
mitochondrial metabolic rhythms, which would indicate that dys-
regulated BMAL1 and CLOCK lead to disrupted mitochondrial 
rhythms in skeletal muscle of people with T2D. We performed ChIP 
sequencing of mouse skeletal muscle using BMAL1 and CLOCK 
antibodies and assessed peaks closest to a gene’s transcription start 
site (TSS) with the highest peak score. First, we assessed whether 
circadian genes identified in myotubes from NGT and T2D donors 
(identified by RAIN) were associated with BMAL1 and CLOCK 
binding to homologous mouse genes (Fig. 5A; Fisher’s exact test, 
FDR < 0.05; Jaccard index indicates the percentage overlap between 
circadian genes and BMAL1/CLOCK bound genes). Rhythmic genes 
of NGT and T2D myotubes were associated with BMAL1 and CLOCK 
binding, while rhythmic genes of T2D myotubes treated with a high 
concentration of glucose and insulin were associated with CLOCK 
binding exclusively. We then performed integrative clustering anal-
ysis between the ChIP-sequencing data, skeletal muscle gene ex-
pression correlated with insulin sensitivity, and circadian genes 
identified within myotubes from NGT and T2D donors incubated 
in the absence or presence of a high concentration of glucose and 
insulin (Fig. 5B). To integrate all different experimental outcomes, 
the data were presented as a binary matrix, where 1 shows the pres-
ence and 0 shows the absence of rhythmicity, correlation with insu-
lin sensitivity, or ChIP-sequencing peaks. The integrated data were 
subjected to clustering analysis, which resulted in 12 distinct clus-
ters (Fig. 5D). Clusters associated with BMAL1 and CLOCK bind-
ing were also associated with circadian rhythm in NGT (Control: 
clusters 8, 9, and 11) and T2D [Control: clusters 9 and 10; high glucose/
insulin (HGI): a few genes in clusters 6 to 11].
Genes that correlated with insulin sensitivity formed a cluster 
with BMAL1 and CLOCK binding and circadian genes within myo-
tubes from NGT donors (cluster 8). We then performed GSEA of 
GO:CC (Fig. 5C). Of note, clusters 3 and 7 were enriched for genes 
associated with the inner mitochondria. Cluster 7 contained no genes 
with circadian rhythmicity in NGT or T2D. Cluster 3 was enriched for 
several cellular compartments, including “extrinsic component of 
mitochondrial inner membrane,” and had very few genes with 
BMAL1/CLOCK binding despite all genes in this cluster showing 
circadian rhythmicity in NGT (but lost in T2D). Thus, mitochondrial 
rhythmic metabolism within NGT may be partly independent of 
genes with CLOCK or BMAL1 binding.
Pharmacological, genetic, and siRNA-mediated disruption 
of inner-mitochondrial metabolism results in altered 
clock-gene expression
Our data provide evidence that mitochondrial metabolic rhythms 
in skeletal muscle from individuals with NGT may be partly inde-
pendent of direct core-clock control. In addition, inner-mitochondrial 
gene expression was associated with whole-body insulin sensitivity. 
Targets involved in inner-mitochondrial functionality can act as 
regulators of molecular-clock expression and function (16, 21). 
Thus, we hypothesized that internal mitochondrial functionality 
may play a role in regulating metabolic and molecular-clock rhythms. 
To test this in myotubes from NGT donors, we used different 
compounds that target mitochondria, namely, carbonyl cyanide 
4-(trifluoromethoxy)phenylhydrazone (FCCP), oligomycin, and a 
mixture of rotenone and antimycin A (Rot/AA). After serum 
shock, we incubated myotubes with these compounds for 4 hours 
(ZT14 to ZT18). We measured mRNA expression of molecular 
clock–associated genes DBP (Fig.  6A) and NR1D1 (Fig.  6B) and 
found that 0.33 M Rot/AA and 2 M FCCP increased mRNA ex-
pression of DBP as compared to vehicle control–treated myotubes. 
In addition, 2 M FCCP and 1 M oligomycin increased mRNA 
expression of NR1D1 as compared to vehicle control–treated myo-
tubes. These data provide evidence that manipulation of inner- 
mitochondrial function may play a role in altering clock-associated 
gene expression in primary human myotubes. However, compounds 
such as these may have off-target effects, and thus, we tested this 
hypothesis in other models.
We sought to manipulate a target that both regulated inner- 
mitochondrial function in myotubes and displayed diurnal behavior 
in vivo in skeletal muscle biopsies from individuals with NGT. Meeting 
these criteria, optic atrophy protein 1 (OPA1) is an established reg-
ulator of inner-mitochondrial morphology and function in skeletal 
muscle (22–25) and displays a day-night change over time of pro-
tein abundance in skeletal muscle from healthy individuals along-
side oscillating mitochondrial function (26). OPA1 did not display 
cycling mRNA in myotubes from NGT or T2D donors when ad-
justed for multiple comparisons. However, OMA1 and HIGD2A are 
responsible for the cleavage and stabilization of OPA1 protein (27, 28), 
respectively, and both genes displayed cycling mRNA patterns in 
myotube cultures from NGT, but not T2D donors (as determined 
via RAIN; fig. S5 and table S1), suggesting circadian regulation of 
OPA1 protein. OPA1 basal gene expression also correlated with in-
sulin sensitivity in the microarray data (Spearman’s correlation, 
FDR = 0.002; fig. S6). To further elucidate the effect of mitochon-
drial disruption in relation to the molecular-clock machinery, we 
performed investigations in a skeletal muscle–specific Opa1−/− mouse 
model. Molecular-clock genes Clock, Bmal1, Nr1d1, and Per3 (Fig. 6C) 
were decreased in Opa1−/− mice, suggesting retrograde signaling 
from OPA1 to the molecular clock.
However, the Opa1−/− mice we studied have a severe myopathic 
phenotype (23), and we thus aimed to recapitulate this finding in myotube 
cultures from NGT donors (Fig. 6, D to H). In synchronized primary 
human skeletal myotubes, small interfering RNA (siRNA)–targeted 
reduction of OPA1 (Fig. 6D) resulted in unchanged BMAL1 (Fig. 6E) 
expression, while NPAS2 (a paralog and substitute of Clock) (29) 
(Fig. 6F), PER2 (Fig. 6G), and PER3 (Fig. 6H) all had altered mRNA ex-
pression in the OPA1-depleted condition. OPA1 silencing also perturbed 
expression of Complex V of the electron- transport chain (Fig. 6I). 
Collectively, these data suggest that manipulating inner-mitochondrial 
metabolism results in altered mRNA expression of clock genes.
Transcription factor–gene network analysis reveals 
divergent circadian transcription factor enrichment 
of NPAS2, NFKB1, and RELA between T2D and NGT
To elucidate putative mechanisms driving altered circadian cross-
talk of the inner-mitochondrial metabolism and clock-gene expres-
sion between myotubes from T2D and NGT donors, we performed 
transcription factor (TF)–gene network analysis on the circadian 
RNA-sequencing data presented in Fig.  1. This TF-gene network 
analysis revealed that genes interacting with CLOCK and ARNTL 
TFs were enriched for circadian genes, inferring a potential binding 
to these TFs in both the myotubes from NGT and T2D donors. How-
ever, NPAS2 was only enriched for circadian TF activity in myo-
tubes from T2D donors. This finding is noteworthy since disruption 
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NPAS2 mRNA expression (Fig. 6). Outside of the core-clock TFs, 
a large cluster of TF-gene interactions was observed within the 
RELA proto-oncogene, NF-kB subunit (RELA) TF-associated gene 
network in NGT, but not T2D, while nuclear factor kappa B subunit 
1 (NFKB1)-related TF-gene interactions were observed exclusively 
in myotubes from T2D donors (Fig. 7B). The circadian genes inter-
acting with RELA, which was exclusively enriched in myocytes 
from NGT donors, included hypoxia-inducible factor-1 (HIF1), 
which plays a role in oxygen sensing and circadian molecular sig-
naling from the core clock to mitochondria (30).
siRNA depletion of OPA1 increases mitochondrial reactive 
oxygen species, and OPA1-mediated changes in clock-gene 
expression can be restored by resveratrol treatment
Our data suggest that the inner mitochondrion is a modulator of the 
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Fig. 5. Mitochondrial pathways are enriched for genes with Clock and Bmal1 binding and are associated with whole-body insulin sensitivity. (A) Enrichment 
analysis between circadian genes and ChIP-sequencing peaks. The association between circadian genes in each disease-treatment group and BMAL1/CLOCK bound 
genes were tested using Fisher’s exact test, and P values are adjusted for multiple testing with the Benjamini-Hochberg method. Columns: BMAL1/CLOCK ChIP-sequencing 
experiments; rows: rhythmic genes in NGT and T2D for both control conditions and high concentration of glucose and insulin treatment groups; numbers: adjusted 
P values (ns: not significant); colors: Jaccard similarity index indicating the percentage of genes overlapping in each dataset. (B) Schematic of experimental design used 
for the integrative analysis. (C) Gene enrichment analysis using ORA (Fisher’s exact test) with the top 10 GO:CC was performed (FDR < 0.10) for each cluster identified in 
(B). (D) Heatmap showing the clusters from the integrative analysis. Binary data used for clustering with “clust” algorithm (67) and resulted in 12 clusters. Columns 
“NGT (Control),” “T2D (Control),” “NGT (high concentration of glucose and insulin),” and “T2D (high concentration of glucose and insulin)” represent circadian (black) and 
noncircadian (white) genes; “M value cor” shows whether a significant (black) correlation between the insulin sensitivity metric (M value) and basal gene expression; 









Gabriel et al., Sci. Adv. 2021; 7 : eabi9654     20 October 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
9 of 19
muscle (Fig. 6), implicating retrograde signaling between OPA1 
and the molecular clock. This signaling pathway may also be rele-
vant for insulin sensitivity, since myotubes from T2D donors have 
altered circadian expression of mitochondrial genes and ablated 
rhythmic metabolism and a moderate alteration of some core-clock 
gene rhythms. Taking this into account, and given the data presented 
in Fig. 7, there are at least two plausible candidate pathways through 
which inner-mitochondrial–mediated signaling to the core clock 
may occur (Fig. 8A). First, nicotinamide adenine dinucleotide 
(NAD+) is a cofactor reflective of mitochondrial metabolism, and 
NAD+-dependent sirtuins are regulators of molecular-clock genes 
(31). Second, oxygen sensing plays a key role in molecular signaling 
from the core clock to mitochondria and vice versa in skeletal mus-
cle via HIF1- (30). HIF1- mRNA displayed circadian rhythms in 
the myotube cultures from the NGT but not the T2D donors in our 
RNA-sequencing data (determined via RAIN Fig. 8B). HIF1- ex-
pression is driven by hypoxia in skeletal muscle and regulated by 
reactive oxygen species (ROS) (32). Thus, we explored the circadian 
mRNA patterns within our RNA-sequencing data of myotubes 
from T2D and NGT donors to identify genes that localize to mito-
chondria, which are associated with ROS processing and NAD+/
NADH (reduced form of NAD+) metabolism. Genes that were cir-
cadian in either T2D or NGT are highlighted in Fig. 8C, with anti-
oxidant enzymes showing circadian regulation in NGT but not T2D 
(GPX1 and GPX4). In addition, several genes involved in NAD+/
NADH were circadian in NGT but not T2D (NAMPT and NADSYN1), 
while NNT was circadian in T2D but not NGT. Of note, SOD2 
(FDR = 0.0005) and NAMPT (FDR = 0.007) correlated with insulin 
sensitivity in our microarray data (Spearman’s correlation, fig. S6). 
Given the apparent rhythmic differences in these metabolic path-
ways, we next assessed the corresponding metabolites in response 
to internal mitochondrion dysregulation. Control cells from NGT 
donors had differences in NAD+ concentration over time, while 






Fig. 6. Pharmacological, genetic, and siRNA-mediated disruption of inner-mitochondrial metabolism results in altered clock-gene expression. (A) mRNA expres-
sion of molecular clock–associated gene DBP in myotubes from NGT donors (n = 4–6 donors). One-way analysis of variance (ANOVA), *P < 0.05 compared to vehicle con-
trol (Con.). (B) mRNA expression of molecular clock–associated gene NR1D1 in myotubes from NGT donors (n = 4 to 6 donors). One-way ANOVA, *P < 0.05 compared to 
vehicle control (Con.). (C) OPA1 and Clock gene expression (Bmal1, Clock, Nr1d1, Per2, and Per3) from skeletal muscle-specific Opa1 knockout (Opa1 mKO) mice (n = 8) 
relative to control (n = 7). Black = Opa1 mKO Opa1 gene expression, purple = core-clock–associated gene expression one-way ANOVA, ***P < 0.001, *P < 0.05. (D) OPA1 
mRNA expression and protein abundance (inset) over the time-course experiment after synchronization in primary human skeletal muscle cells treated with siRNA target-
ing OPA1 (siOPA1) (n = 6) compared to Scramble siRNA (n = 6). (E to H) Primary human skeletal muscle cells treated with siOPA1 (n = 6). Molecular-clock genes BMAL1 (E), 
NPAS2 (F), PER2 (G), and PER3 (H). †P < 0.05 overall difference siOPA1 versus Scramble. ****P < 0.0001, *P < 0.05 siOPA1 versus Scramble at time point (two-way ANOVA). 
Genes are shown in synchronized cells and presented at each ZT after serum shock. (I) Protein abundance of electron transport complexes. Orange, siOPA1 (n = 4–6 donors). 
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concentration that did not differ over time. However, there was no 
difference in NAD+ concentration between siOPA1 and Scramble (Fig. 8D). 
We then assessed mitochondrial ROS levels using live-cell micros-
copy and measured MitoSOX fluorescence, indicative of mitochondrial 
ROS. OPA1-depleted myotubes had increased MitoSOX fluores-
cence when perfused with Tyrode’s solution, as compared to Scramble 
control (Fig.  8E). We also treated OPA1-depleted myotubes with 
resveratrol. Resveratrol can act as an antioxidant and reduce HIF1- 
activity, in addition to increasing SIRT1 activity (33). Resveratrol 
reduced mitochondrial ROS levels in OPA1-depleted myotubes 
and rescued the OPA1-mediated changes in NPAS2 expression 
(Fig. 8, F and G). Our results provide evidence to suggest that OPA1 
regulation of mitochondrial ROS levels constitute a feedback loop 
permitting bidirectional control of circadian metabolism in skele-
tal muscle.
DISCUSSION
Defective mitochondrial function and content is implicated in skel-
etal muscle insulin resistance and T2D pathogenesis (24,  34,  35). 
Our data provide mechanistic insight into this metabolic dysfunc-




















































































































Fig. 7. TF-gene interaction network analysis reveals divergent circadian TF enrichment of NPAS2 and RELA between T2D and NGT. (A) Schematic overview of 
primary cell culture circadian experiment and RNA sequencing. RNA sequencing of primary human skeletal muscle cells (myotubes) from men with NGT (n = 7) or T2D 
(n = 5). These data were used for the TF-gene network analysis. (B) The human TF-gene interactions were retrieved from TRRUST database version 2. Genes interacting 
with each TF were checked for enrichment with rhythmicity using Fisher’s exact test (FDR < 0.10). Large orange dots: TFs; small blue open circles: genes. Black and red lines 
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Fig. 8. siRNA depletion of OPA1 increases mitochondrial ROS, and OPA1-mediated changes in clock-gene expression can be restored by resveratrol. (A) Circadian 
rhythms, transcription factor activity, and circadian inner-mitochondrial membrane metabolism are disrupted in T2D. Changes in NAD+/NADH metabolism and ROS sig-
naling constitute a feedback loop permitting bidirectional control of circadian metabolism. (B) Time course of HIF1 mRNA in synchronized myotubes from donors with 
NGT (n = 7) or T2D (n = 5). Lines show harmonic regression fits, the solid line indicates circadian (FDRRAIN < 0.1) genes, and dashed lines indicate non-circadian genes. 
(C) mRNA expression of antioxidant enzymes, and those linked to NAD+/NADH metabolism that localize to mitochondria in myotube cultures as described in (B). (D) NAD+ 
concentration in synchronized myotubes from NGT donors (n = 6) treated with siRNA against a scrambled sequence (blue) or OPA1 (orange), two-way ANOVA, †overall 
time effect, *P < 0.05 difference between time points (12 versus 20 hours, and 28 versus 36 hours) only in Scramble. (E) Live-cell microscopy measuring MitoSOX fluores-
cence, indicative of mitochondrial ROS in myotube cultures as described in (D). Mixed-effects analysis, †P < 0.05 overall difference between conditions, ***P < 0.0001 
difference between siOPA1 versus siOPA1-resv, Scramble versus siOPA1, and Scramble versus siOPA1-resv. (F) OPA1 and (G) NPAS2 mRNA assessed at ZT28 in synchro-
nized myotubes from NGT donors (n = 4) treated with siRNA against a scrambled sequence (blue) or OPA1 (orange). Cells were incubated in the absence (vehicle control) 
or presence of 10 M resveratrol. Relative to Scramble siRNA at ZT28. Two-way ANOVA, †P < 0.05 overall effect siRNA (Scramble versus siOPA1), **P < 0.01 control-Scramble 
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intrinsically disrupted circadian rhythm at the global transcriptom-
ic and molecular-clock–specific level. Furthermore, an acute treat-
ment of myotubes with a high concentration of glucose and insulin, 
partially mimicking a diabetic milieu, somewhat replicates the re-
duced number of rhythmic genes in T2D. However, clear differences 
between T2D and treatment with high glucose and insulin concen-
trations exist, including the number, percentage, and cellular loca-
tion of genes at each peak time. These data suggest an intrinsic 
conservation of the T2D circadian signature in primary myocytes. 
This finding is consistent with data demonstrating that induced 
pluripotent stem cells from donors with T2D that were differentiated 
into myoblasts had multiple defects, including reduced insulin- 
stimulated glucose uptake and reduced mitochondrial oxidation 
(36). These T2D-associated defects were conserved despite the 
robust manipulations that the cells undergo. How cultured myo-
cytes from T2D donors preserve a dysfunctional phenotype, includ-
ing insulin resistance (37, 38), has not been fully elucidated, but 
likely reflects genetic background and epigenetic mechanisms. Our 
data reveal that an intrinsic disruption of circadian biology in 
skeletal muscle may also be present in individuals with T2D. The 
cause of this disruption is unknown, but in addition to inherited 
factors, glucoregulatory disturbances, cumulative effects of sedentary 
lifestyle, sleep deprivation, and nutritional and hormonal factors are 
likely to play a role (39, 40). Thus, genetic/epigenetic components 
and environmentally driven factors affect the circadian biology of 
metabolism.
Our results demonstrate that dysregulated rhythmic mitochondrial 
metabolism may play a role in mediating the disrupted rhythmic 
cellular metabolism and molecular-clock machinery in primary 
myotubes from individuals with T2D. Mitochondrial diurnal rhythms 
in oxidative capacity and oxygen metabolism have been demon-
strated in several tissues in  vivo, including skeletal muscle (13). 
Skeletal muscle diurnal mitochondrial rhythms are more likely to 
emanate from mitochondrial membrane dynamic processes, regu-
lated by rhythmic proteins, such as OPA1 and FIS1, rather than a 
day-night rhythm of mitochondrial biogenesis and content (26, 41). 
Mitochondrial membrane dynamics also demonstrate circadian 
behavior in several peripheral tissues (41); however, transcriptional 
control of these pathways is tissue specific (35, 42). For example, 
while Drp1, Mfn1/2, and Opa1 are not direct targets of the clock 
machinery in liver (43), Mfn1 and Opa1 are decreased in cardiac 
muscle of Bmal1−/− mice (44).
When assessing functional differences in the OCR over a 16-hour 
period, we observed differential rhythmicity between the myotubes 
from the NGT and T2D donors, with a lack of rhythmicity in 
T2D. The lack of a 24-hour rhythm in OCR in myotubes from the 
NGT and T2D donors is perplexing, but these cells are cultured in 
the absence of physiological or environmental cues, which may play 
a role. In addition, the serum shock cell-culture conditions were op-
timized to synchronize rhythmicity of circadian genes. Thus, we 
cannot exclude the possibility that the OCR rhythm in primary cells 
has a less robust 24-hour cycle as compared with core-clock gene 
expression. We speculate that OCR and mitochondrial function, 
which display changes over time in a diurnal manner in human 
skeletal muscle in vivo (26), maintain a physiological diurnal rhythm 
that can be fine-tuned in response to external stimuli, such as nutrient 
intake and physical activity.
In the current study, ChIP sequencing revealed that inner- 
mitochondrial cellular compartments were enriched for genes highly 
associated with insulin sensitivity, which were also direct targets of 
both CLOCK and BMAL1  in skeletal muscle. Few of these genes 
were also circadian in myotube cultures from donors with T2D 
when treated with high concentrations of glucose and insulin. 
Furthermore, few genes with CLOCK and BMAL1 binding coalesced 
with inner-mitochondrial genes in myotubes from donors with NGT, 
despite the similar enrichment of these pathways when assessing cy-
cling genes with peaks at ZT24 and genes that correlated with insulin 
sensitivity in vivo. Metabolic pathways are independently capable 
of maintaining circadian rhythms in vitro (45), and our data suggest 
that maintenance of circadian mitochondrial metabolism in NGT 
may be partly independent of genes with core-clock binding.
Mitochondrial metabolism plays a role in bidirectional regula-
tion of diurnal metabolism in peripheral tissues (46). Here, we report 
that myotube cultures from donors with NGT displayed more robust 
mitochondrial metabolic rhythms as compared with T2D. Mito-
chondrial rhythms in individuals with NGT may help to maintain 
the diurnal metabolic rhythm in skeletal muscle. In addition, 
manipulating mitochondrial membrane metabolism may alter the 
rhythmic expression of molecular-clock genes (16,  21), although 
the signaling mechanism between mitochondrial metabolism and 
the molecular clock has not been elucidated. Our results provide 
evidence that OPA1 depletion disrupts molecular-clock genes NPAS2, 
PER2, and PER3 in primary myocytes. Depletion of OPA1 through 
either constitutive loss in mouse skeletal muscle or transient siRNA- 
mediated silencing in primary human myotubes resulted in differ-
ing effects on some core-clock genes. Of note, Opa1−/− mice have a 
myopathic phenotype (23), which may contribute to these differ-
ences. Collectively, we provide evidence that manipulating inner- 
mitochondrial metabolism alters mRNA expression of clock genes 
in skeletal muscle.
Mitochondrial respiration and ROS production are tightly linked, 
and alongside mitochondrial capacity and oxygen consumption, 
antioxidant proteins and ROS production also display circadian ac-
tivity (41). In our study, mRNA expression of antioxidant enzymes 
that localize to mitochondria (GPX1 and GPX4) were rhythmic in 
myotube cultures from donors with NGT, but not T2D. The afore-
mentioned enzymes are involved in the detoxification of hydrogen 
peroxide, a known regulator of HIF1- activity (32), which was also 
rhythmic in myotube cultures from donors with NGT, but not T2D. In 
addition, TF-gene network analysis demonstrated divergent circadian 
TF enrichment of NFKB1 and RELA between T2D and NGT. Both 
NFKB1 and RELA are subunits of nuclear factor kappa-light-chain-
enhancer of activated B cells, which is highly responsive to ROS 
(47). Moreover, the circadian genes interacting with RELA, which 
was exclusively enriched in myocytes from NGT donors, included 
HIF1. HIF1- plays a key role in mediating signaling from the core 
clock to mitochondria and vice versa in skeletal muscle (30). Our 
data indicate that altered rhythms of mitochondrial respiration and 
ROS handling in myotube cultures from donors with T2D may be 
partly responsible for the ablated rhythm of HIF1- expression. In 
support of this, the OPA1-mediated increase in NPAS2 expression 
and mitochondrial ROS were rescued by treatment with resveratrol, 
an antioxidant and HIF1- modulator. Collectively, our data show 
cross-talk between the inner mitochondrion and the molecular 
clock, with genes of these pathways rhythmically dysregulated in 
T2D. Dysfunction of the inner mitochondrion in peripheral tissues 
is implicated in the pathogenesis of insulin resistance and T2D, 
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capacity, and reduced metabolic flexibility (35). Thus, disturbances 
in daily rhythms of mitochondrial activity may contribute to skele-
tal muscle insulin resistance in T2D.
In conclusion, we show disturbances in the intrinsic rhythmicity 
of gene expression and metabolism in skeletal muscle cells of indi-
viduals with T2D. We find that the core molecular clock machinery 
is still largely intact in T2D, indicating that the major impact of di-
abetes is on the clock output, such that daily rhythms of metabolic 
and other genes are disturbed. This dysregulation is evident in 
myocytes in the absence of systemic factors, hormones, nutritional 
cues, or direct influence of the central or other peripheral clocks. 
Moreover, inner mitochondrion–associated genes displayed im-
paired cycling behavior in T2D. These inner-mitochondrion genes 
are also associated with insulin sensitivity and are under bidirec-
tional regulation of circadian metabolism in skeletal muscle. The 
dysregulation of circadian metabolism in skeletal muscle of people 
with T2D underscores the need to take circadian biology into ac-
count and consider approaches in chronomedicine (48) when pre-
scribing pharmacological therapy, particularly treatments that affect 
mitochondrial function. Our findings provide mechanistic insight 
into T2D pathophysiology and have clinical implications into the 
link between insulin sensitivity and environmental triggers that are 
associated with altered metabolism, including impaired sleeping 
patterns, social jet lag, or shift-work.
MATERIALS AND METHODS
Human study methods
Study group and skeletal muscle biopsy procedure
Study groups included individuals with NGT, as determined by oral 
glucose tolerance test OGTT, or T2D. Written informed consent was 
obtained from all participants. The study protocol was approved by 
the regional ethics board in Stockholm, Sweden. The participants 
were instructed to refrain from physical exercise 48 hours before the 
visit. All investigations were performed in the morning after an 
overnight fast. Anthropometric measurements were taken, and blood 
samples were obtained for clinical chemistry analysis. After applica-
tion of local anesthesia (10 mg/ml; mepivacaine hydrochloride, 
AstraZeneca, Cambridge, UK), a biopsy was obtained from m. vastus 
lateralis using a Weil-Blakesley conchotome instrument (Agnthos, 
Sweden). Biopsies were cleared from any visible fat, connective tis-
sue, or blood vessels and either used directly to prepare primary 
muscle cell cultures or immediately frozen in liquid nitrogen and 
stored at −80°C until microarray analysis. The clinical characteris-
tics of the NGT (n = 7) or T2D (n = 5) donors for the muscle cell 
culture studies are presented in table S4.
Cell culture
Primary myoblasts from skeletal muscle biopsies from men with 
NGT and T2D were grown in Dulbecco's modified Eagle’s medium/
nutrient mixture F-12 (DMEM/F12) + GlutaMAX with 16% fetal 
bovine serum (FBS) and 1% antibiotic-antimycotic (100×). Differ-
entiation was induced at 80% confluence by incubating the cells for 
4 to 5 days in fusion medium consisting of 76% DMEM GlutaMAX 
with glucose (25 mM), 20% M199 (5.5 mM), 2% Hepes, and 1% 
antibiotic-antimycotic (100×) with zinc sulfate (0.03 g/ml) and 
vitamin B12 (1.4 mg/ml), with a further addition of apo-transferrin 
(100 g/ml) and insulin (0.286 IU/ml) before use. Experiments 
were performed on differentiated myotubes after an additional 3 to 
5 days of incubation in the same media containing 2% FBS (postfu-
sion media).
Circadian experiments
After postfusion, DMEM with glucose (5.5 mM) was used in the 
postfusion medium to create a low-glucose condition, or cells were 
treated with a high concentration of glucose and insulin (50 nM 
insulin and 25 mM glucose) before serum shock. After 22 hours, 
cells were synchronized by serum shock (media containing 50% 
FBS, 2 hours) (49) and then switched back to low-glucose media. 
Skeletal muscle myotubes from men with either T2D or NGT were 
lysed at 6-hour intervals from 12 to 54 hours. ZT was determined as 
time after synchronization.
RNA sequencing
RNA was checked for quality using the Agilent RNA 600 nano kit 
and Bioanalyser instrument (Agilent Technologies, Santa Clara, 
CA). Aliquots of RNA (1 g) were analyzed using the Illumina 
TruSeq Stranded Total RNA with Ribo-Zero Gold protocol (Illumi-
na) as previously described (50, 51). Ribosomal RNA was removed 
from the sample using 35 l of rRNA removal beads (Illumina) on a 
magnetic plate followed by cleanup of the ribosomal-depleted RNA 
with 193 l of Agencourt RNAClean XP beads (Beckman Coulter), 
70% ethanol wash, and elution into 10 l elution buffer (Illumina). 
The RNA sample was fragmented for 4 min at 94°C in Elute, Prime, 
Fragment High Mix (Illumina) and then subjected to first-strand 
cDNA synthesis with 1 l of Superscript III reverse transcriptase 
(Life Technologies) per sample using a thermocycler programmed 
to 25°C for 10 min, 50°C for 15 min, and 70°C for 15 min. Second- 
strand cDNA was synthesized by addition of Second-Strand Marking 
Master Mix, and samples were incubated at 16°C for 60 min. Samples 
were subjected to another bead cleanup before A-tailing and liga-
tion of adapters as per kit instructions (Illumina). Following a third 
bead cleanup, samples were enriched for DNA fragments by ampli-
fication using the Illumina polymerase chain reaction (PCR) Primer 
Cocktail and PCR Master Mix, subjected to 98°C for 30 min, followed 
by a predefined cycle (98°C for 10 s, 60°C for 30 s, and 72°C for 30 s) 
that was repeated 3 to 15 times, on the basis of each individual sample, 
and finally incubated for 5 min at 72°C. Samples were cleaned and 
validated for DNA concentration using the Qubit dsDNA HS assay kit 
(Invitrogen) and for base pair size and purity using the Agilent High 
Sensitivity DNA chip and Bioanalyzer instrument. Libraries were 
subjected to 100-bp single- end sequencing on the X Ten platform 
(Illumina) at the Beijing Genomics Institute, Hong Kong, China. 
Approximately 20 million reads per sample were assigned to genes 
with 18,482 genes surviving the expression threshold.
RNA-sequencing data analysis
RNA-sequencing reads ( _ n ≈ 40 M) from FASTQ files were quality- 
trimmed using Trim_Galore (v0.4.3). Trimmed reads were aligned 
using STAR (v2.5.3a) (52) aligner with Ensembl human annotation 
(GRCh38, release 92) (53), and gene features were counted using 
featureCounts from subread (v1.5.2) package (54) resulting in 27 M 
uniquely mapped and 20  M assigned reads to genomic features 
(genes) on average, respectively. The lowly expressed genes were 
discarded from downstream analysis using filterByExpr function 
from edgeR package (55) resulting in 18,482 genes. As an apparent 
batch effect was introduced by participants (fig. S1), this batch effect 
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further downstream rhythmicity (RAIN) and differential rhythmicity 
(DODR) analysis as these tools do not consider any batch effect by 
default. The batch-corrected counts per million (CPM) values were 
in log2 scale.
Rhythmicity and differential rhythmicity analysis
P values for rhythmicity were assessed using RAIN (17) with longi-
tudinal method and adjusted for multiple testing using the 
Benjamini-Hochberg method. Genes with adjusted P value below 
0.10 (FDRRAIN < 0.10) were considered as rhythmic. We chose RAIN 
because this algorithm detects both symmetric and nonsymmetric 
wave forms (17). To compare two groups for differential rhythmicity 
analysis, subsetting genes with rhythmic behavior is essential as 
comparing genes that have no rhythmic properties can result in 
false positives. Therefore, meta P values using a beta-distribution–
based approach (the same as what DODR uses internally) from both 
conditions were calculated and adjusted for multiple testing using 
the Benjamini-Hochberg method. The genes with adjusted meta 
P values below 0.10 were subsetted for the subsequent differential 
rhythmicity analysis. Differential rhythmicity analysis was performed 
on mean-centered logCPM values (batch-corrected) between 
myotubes from NGT and T2D donors (control and HGI group, 
separately) by using DODR (57) with “robust” method and resulting 
meta P values were adjusted for multiple testing using the Benjamini- 
Hochberg method. It is essential to mean-center the logCPM values 
as DODR internally assumes identical means to test for differential 
rhythmicity while setting the normalization parameter to false. 
Genes with adjusted meta P value below 0.10 (FDRDODR < 0.10) were 
considered differentially rhythmic.
Circadian amplitude estimations
A harmonic regression model using HarmonicRegression R pack-
age (58) with first-degree polynomial component (linear regres-
sion) was fit to (participant) batch-corrected logCPM values. As 
relative amplitudes are dimensionless compared to absolute ampli-
tudes, it allows for a proper comparison across different conditions 
and experiments while normalizing for systematic errors (59). Since 
our batch effect (from individuals)–corrected RNA expression values 
were in log2 scale (logCPM), we needed to perform appropriate trans-
formations to calculate the relative amplitudes. The fold-change 
amplitude (Afc) is defined as the ratio between the peak (emax) and 
the trough (emin) values
  A fc =  
 e max  ─ e min (1)
Twice the absolute amplitude calculated from log2-transformed 
data (Alog) is equal to log2 of fold-change amplitude (Afc)
  log 2 ( A fc ) =  log 2 ( e max ) − log 2 ( e min ) = 2 .  A log (2)
  2 .  A log =  log 2 ( A fc ) 
Considering the relationship between the fold-change ampli-
tude and the relative amplitude (59)
  A fc =  
1 +  A rel  ─1 −  A rel 
(3)
The relative amplitude (Arel) can be derived by solving Eqs. 2 and 
3 to explain the relationship between Arel and Alog as
  A rel =   2 
2. A log  − 1 ─
 2 2. A log  + 1
(4)
To compare the relative amplitudes between T2Ds and NGTs, 
log2 ratios were calculated for each treatment group (control and HGI)
  log 2 ( A rel ) =  log 2 ( 
 A  rel T2D   ─ A  rel NGT  
 ) (5)
The log2(Arel) of circadian genes was compared to log2(Arel) of 
noncircadian genes using a two-sided Kolmogorov-Smirnov test 
(Fig. 2A). Individual relative amplitudes of circadian genes of NGT 
and T2D groups were compared to each other using paired Wilcoxon 
rank sum test (Fig. 2B).
Heatmaps for the circadian gene expression
The RNA-sequencing gene expression in our cohort had an increas-
ing or decreasing linear trend over time. Therefore, we have fitted a 
harmonic regression model with first-degree polynomial to our 
data to show the rhythmic patterns for each gene
  E = a . sin ( 
2 ─ w t ) + b . sin ( 
2 ─ w t ) + (c + d . t) (6)
where E is the fitted expression value, w is the period (24 hours), t is 
the time in hours, and a, b and c, d are the coefficients for the 
harmonic regression and linear regression, respectively. However, 
visualization of the rhythmic data with a linear trend on a heatmap 
is problematic owing to the extreme values masking the peak and 
trough values. Therefore, we have removed the linear trend from 
our data by fitting a linear line and subtracting it from the previously 
fitted harmonic regression with linear trends
  E ′ = E − ( +  . t) (7)
where E′ is the fitted expression values without linear trends and  
and  are the coefficients for the linear regression. Before linear trend 
removal, expression data are mean-centered or z score–transformed 
across time points for each NGT and T2D group to show the rela-
tive amplitude differences (Fig. 2B) or rhythmic patterns (fig. S2), 
respectively.
Gene enrichment analysis
Gene enrichment analysis was performed by using ORA throughout 
this study. For biological interpretation of the biological processes, 
we used Reactome pathways (19), while GO (60) CC were used to 
identify the enrichment of subcellular compartments. clusterProfiler 
(61) R package was used to analyze all gene enrichment results. 
Ontology terms (Reactome, GO:CC) with an adjusted P value, using 
the Benjamini-Hochberg method, below 0.10 were considered to be 
significantly enriched.
As we aimed to investigate the biological pathways and CC 
associated with the circadian genes, we subsetted circadian genes by 
disease-treatment groups (Fig. 1D) and peak times (Fig. 3F) and 
analyzed enrichment from Reactome pathways and GO:CC using 
ORA, respectively. Similarly, genes with significant correlations 
between insulin resistance (M value) and basal gene expression 
(Fig. 4C) were tested for GO:CC enrichment using the ORA method. 
The top 10 enriched terms ranked by gene ratio (the number of 
significant genes associated with the given the ontology term divided 
by all significant genes that are a member of any ontology term) were 
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network with the top five enriched (ORA) GO:CC terms ranked by 
gene ratio (the so-called CNET plot) was generated to show the 
involvement of an individual gene, together with the Spearman 
correlation coefficient (Fig. 4D).
Last, clustering analysis revealed 12 distinct clusters from inte-
grative analysis using binary input for the presence/absence of 
rhythmicity in disease-treatment groups, insulin sensitivity correla-
tion with basal gene expression, and BMAL/CLOCK binding. The 
genes in each cluster were analyzed using the GO:CC database with 
the ORA method (Fig.  5C), similar to the analysis performed in 
Figs. 1D and 3F.
Hyperinsulinemic-euglycemic clamp procedure
This study group was handled as described in the “Human study 
methods” section. The clinical characteristics of the men with 
NGT (n = 24) or T2D (n = 25) enrolled in the gene array and hyper-
insulinemic-euglycemic clamp study are reported in table S5. After 
a 45-min rest, the study participants underwent a hyperinsulinemic- 
euglycemic clamp as previously described (62). Following an in-
travenous bolus dose of insulin (1600 mU/m2 body surface area), 
insulin was infused intravenously at a rate of 40 mU/m2 per minute 
for 2 hours, and a variable intravenous infusion of glucose (200 mg/ml) 
was used to maintain euglycemia between 81 and 99 mg/dl (4.5 to 
5.5 mM). The infusion rate of glucose during the last 60 min of the 
clamp, when insulin levels are in a steady state, was used to calculate 
whole-body glucose disposal rates (M value).
ChIP sequencing
Tissue harvesting
Animal procedures were conducted in accordance with institutional 
guidelines for the care and use of laboratory animals as approved by 
the University of Florida Institutional Animal Care and Use Com-
mittee. For the ChIP-sequencing data, two replicate samples for 
BMAL1 and CLOCK were used. Each sample required pooling gastro-
cnemius muscle from 10 adult C57BL/6J male mice (the Jackson 
Laboratory, Farmington, CT, USA). The mice were entrained to a 
12-hour light/12-hour dark schedule, and all tissues were collected 
at ZT2 and frozen immediately.
ChIP-sequencing sample preparation
For the CLOCK ChIP-sequencing samples, skeletal muscle was ho-
mogenized (muscle:buffer ratio, 1:10) in lysis buffer [10 mM Hepes 
(pH 7.5), 10 mM MgCl2, 60 mM KCl, 300 mM sucrose, 0.1 mM EDTA 
(pH 8.0), 0.1% Triton X-100, and 1 mM dithiothreitol (DTT)] with 
ethylene glycol-bis (succininic acid) N-hydroxysuccinimide ester 
(Bio-world) (63). The reaction was stopped with 1 M tris (pH 7.5) 
buffer (final concentration of tris was 20 mM), and formaldehyde 
was added (final concentration of 1%). Samples were incubated for 
25 min at room temperature, and cross-linking was stopped by adding 
glycine to 125 mM.
For the BMAL1 ChIP-sequencing samples, we followed a proto-
col outlined previously (64). Skeletal muscles were homogenized in 
lysis buffer containing 1% of formaldehyde. Samples were incubated 
at room temperature for 25 min, and cross-linking was stopped by 
adding glycine to 125 mM.
For all samples, myonuclei were isolated from skeletal muscle 
homogenates as previously described (64), and samples were incu-
bated with the appropriate antibody at 4°C overnight. Samples were 
washed and then incubated at 65°C overnight to decross-link. Last, 
ribonuclease, 5 M NaCl, and proteinase K were added, and samples 
were incubated at 55°C for 1 hour.
DNA was recovered with a PCR purification kit (Qiagen), and 
the ChIP-sequencing library was prepared by using NEBNext Ultra 
DNA library prep kit for Illumina. Library quality was determined 
by Tapestation and quantitative PCR. Sequencing parameters were 
paired-end 100 bp run with approximately 40 M reads per sample 
on the HiSeq 3000 Illumina sequencing system.
ChIP-sequencing data analysis
The reads were aligned to Mus musculus genome assembly GRCm38 
(mm 10) using Bowtie2 (65) with the --sensitive-local option, which 
does not require that the entire read aligns from one end to the other. 
The biological replicates of the aligned reads were merged for 
CLOCK, BMAL1, and input, respectively. Homer software (66) was 
deployed to perform peak calling for the CLOCK sample and the 
BMAL1 sample with the input sample as background. The default 
FDR rate threshold 0.001 was used to detect significant peaks.
Integrative analysis of circadian rhythmicity, insulin 
sensitivity, and BMAL1/CLOCK chromatin binding
To identify the gene patterns across different experimental proce-
dures, an integrative analysis approach was applied to circadian genes 
(RNA sequencing), insulin sensitivity correlations (M value versus 
basal gene expression from microarray study), and BMAL1/CLOCK 
chromatin binding (ChIP sequencing). Both gene expression cor-
relations with M values and BMAL1/CLOCK ChIP-sequencing ex-
periments were performed on mice; therefore, we have identified 
the homologous genes between mouse and human and only included 
those genes for further downstream analysis. ChIP-sequencing 
peaks close to a gene’s TSS with maximum peak score are assigned 
to that gene. A binary matrix was created with the circadian rhythmicity 
(1: rhythmic, 0: nonrhythmic), Spearman correlation between insu-
lin sensitivity (M value) and basal gene expression (1: significant, 0: 
nonsignificant), and BMAL1/CLOCK binding (1: bound, 0: not 
bound). The resulting matrix was used for clustering analysis using 
the “clust” algorithm (67) to identify groups of genes showing similar 
patterns. This resulted in 12 different clusters. Those 12 clusters 
were used for gene enrichment analysis using the ORA method and 
the GO:CC database.
The circadian genes associated with BMAL1/CLOCK binding 
were identified by overlapping each group, NGTs and T2Ds, with 
both treatment conditions separately. The overlaps were tested by 
Fisher’s exact test, and the resulting P values were adjusted by the 
Benjamini-Hochberg method. Adjusted P values below 0.05 were 
considered as statistically significant. Overlapping gene percentage, 
also known as Jaccard index, was used for showing the similarity 
between the overlaps (Fig. 5A).
TF-gene interaction network of rhythmic genes
The TF-gene interactions for human were retrieved from TRRUST 
database version 2 (68). The nature of the interaction (activation, 
inactivation, and unknown) was omitted because of its complexity 
and experimental setup differences. Since all gene IDs were presented 
as gene symbols/names, we converted all gene symbol IDs to 
Ensembl IDs to conform to our results, considering that the same gene 
symbol ID can match with several Ensembl IDs. Genes interacting 
with each TF were extracted and checked for enrichment for NGT 
and T2D rhythmic genes, separately, using Fisher’s exact test (alter-
native hypothesis: the OR is greater than 1). Genes with no overlap 
between rhythmic genes and TF-gene pairs were excluded from the 
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genes in both NGT and T2D groups. P values were adjusted for 
multiple testing using the Benjamini-Hochberg method (69) for the 
NGT and T2D groups, separately. Enrichments with adjusted P value 
below 0.10 were considered significant.
Animal models
Myo-Cre Opa1−/− mice
Animal work was performed in compliance with guidelines estab-
lished by the University of Barcelona Committee on Animal Care. 
Opa1loxP/loxP mice were generated as previously reported (23, 70). 
The Myo-Cre OPA1 (Opa1 mKO) mouse line was generated by cross-
ing homozygous OPA1loxP/loxP mice with a strain expressing Cre re-
combinase under the control of the myogenin promoter and the 1-kb 
mouse myocyte enhancer factor 2, thus yielding a transgene called 
Myo-Cre (71). Cre OPA1 littermates were used as controls for 
knockout mice. Mice were kept under a 12-hour dark/light cycle 
and were provided standard chow diet and water ad libitum. Four-
month-old male mice were used in all experiments. On the experi-
mental day, mice were anesthetized with isoflurane, euthanized by 
cervical dislocation, and tibialis anterior muscles were harvested and 
immediately frozen in liquid nitrogen for subsequent analysis.
Mitochondrial-disrupting compounds and circadian studies
Primary human skeletal muscle cells from men with NGT were used 
to study the effect of compounds FCCP, rotenone A, antimycin A, 
and oligomycin on molecular-clock gene expression. Primary skeletal 
muscle cells were grown and differentiated as described above. The 
cells were synchronized as described above, compounds or vehicle 
control were added at ZT14 after synchronization, and cells were 
harvested after 4-hour exposure (ZT18). Compounds were rotenone/
antimycin A (0.38 m), FCCP (2 m), and oligomycin (1 m). Cells 
were harvested to collect RNA, and core-clock gene mRNA expres-
sion was measured by quantitative reverse transcription PCR. A 
lactate dehydrogenase (LDH) assay (no. 11644793001, Roche, Basel, 
Switzerland) was performed according to the manufacturer’s in-
structions to determine cell viability after treatment with compounds. 
Cell supernatant was collected when harvesting RNA; 100 l of this 
supernatant was added to a 96-well plate, along with 100 l of test 
solution (2.2% lyophilizate catalyst solution +97.8% dye solution) 
and incubated at room temperature for 30  min. Absorbance was 
measured at 490 and 690 nm (for background), and LDH content 
for each sample was calculated as OD490 (optical density at 490 nm) − 
OD690, presented as percentage relative to control. There were no 
differences in LDH concentration in any condition (fig. S7).
Gene silencing and metabolic studies
Opa1 silencing
Primary human skeletal muscle cells from men with NGT were 
used for the study of OPA1 silencing. Primary skeletal muscle cells 
were grown and differentiated as described above. After switching 
to postfusion media, cells were transfected as previously described 
(21), using 10 M of either Silencer Select (Thermo Fisher Scientific, 
Waltham, MA) Negative Control No. 2 (no. 4390847) or validated 
siRNAs against OPA1 (no. s9852), for two separate 5-hour transfec-
tion periods separated by ~48 hours.
Metabolic phenotyping of cells
To assess the mitochondrial function of primary human skeletal 
muscle cells, myotubes were subjected to a Seahorse XF Mito Stress 
Test using the manufacturer’s instructions for timing (Agilent, Santa 
Clara, CA) as previously described (21). OCR and extracellular 
acidification rates (ECARs) were measured at three time points 
under unstimulated conditions and then after treatment with 1 M 
oligomycin, 2 M FCCP, and 0.75 M rotenone + antimycin A. OCR 
and ECAR were normalized to the protein concentration, as quan-
tified by a Pierce bicinchoninic acid (BCA) protein assay kit (Thermo 
Fisher Scientific). Myotube cultures either from men with NGT 
(n = 5) or from those with T2D (n = 5) were subjected to a Mito 
Stress Test (fig. S1) under the same conditions as previously described, 
except these cells were measured at ZT24 after synchronization as 
described in the “Circadian experiments” section. For circadian 
Seahorse XF experiments (time course of basal OCR, Fig. 3H), myo-
tube cultures from men with either NGT (n = 5) or T2D (n = 5) 
were synchronized as described in the “Circadian experiments” sec-
tion. Myotubes were measured sequentially, i.e., the same cells were 
measured at all time points in buffered media, and only basal oxy-
gen consumption was measured. This allowed minimal disturbance 
to cells and enabled measurements of diurnal oxygen consumption 
in a method derived from previous work (31).
NAD measurements of cells after OPA1 silencing
NAD levels were assessed in primary human skeletal muscle cells 
after OPA1 silencing using an enzymatic cycling assay (72). Cells 
were harvested with trypsin, and the cell pellet was dissolved in 200 l 
of 0.6 M perchloric acid and subjected to centrifugation for 3 min at 
13,000g. The supernatants were transferred to new tubes and diluted 
1:100 in 100 mM Na2HPO4 (pH 8). An aliquot (100 l) of the diluted 
extract was pipetted into a 96-well plate, and a reaction mix (100 l) 
containing 100 mM Na2HPO4, 10 M flavin mononucleotide, 2% 
ethanol, alcohol dehydrogenase (90 U/ml), diaphorase (130 mU/ml), 
resazurin (2.5 g/ml), and 10 mM nicotinamide was added. Fluorescence 
(excitation 540 nm/emission 580 nm) was measured over 30 min, 
and the NAD content was calculated from a standard curve and normal-
ized to the protein concentration. Protein was extracted by dissolving 
the cell pellet (after perchloric acid precipitation) in 200 l of 0.2 M 
NaOH, incubating at 95°C for 5 min, and centrifugation for 5 min 
at 13,000g. Protein concentration was determined on the supernatant 
using the BCA assay (23227, Thermo Fisher Scientific, MA).
Resveratrol treatment
Human primary skeletal muscle cells were grown, differentiated, 
and synchronized as described above. Cells were treated with either 
10 M resveratrol (no. R5010, Merck KGaA, Darmstadt, Germany) 




RNA quality was assessed and ensured using the Experion Automated 
Electrophoresis System (Bio-Rad Laboratories, CA). Affymetrix GeneChip 
Human Transcriptome Array 2.0 (Thermo Fisher Scientific, MA) was 
used for the whole-transcriptome analysis performed at the Bio-
informatics and Expression Core facility at Karolinska Institutet, 
Huddinge, Sweden. Amplified and biotinylated sense-strand DNA 
targets were generated from total RNA using the WT Plus Kit (Thermo 
Fisher Scientific, MA). Fragmented and biotinylated sense-strand 
DNA target (5.5 g) were hybridized to the arrays in GeneChip 
Hybridization Oven 645 at 45°C for 16 to 18  hours. Arrays were 
washed and stained in GeneChip Fluidics Station 450 before scan-
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Normalization and calculation of microarray (n = 49) gene ex-
pression was performed with the Robust Multichip Average ex-
pression measure using oligo R package (v1.56.0) (73). Probeset 
IDs were matched to their corresponding Ensembl IDs using 
biomaRt R package (v2.48.2). The nonunique probesets mapping 
to multiple Ensembl IDs were filtered out, and the probesets with 
signal value below 4  in at least 24 samples (minimum “Disease” 
group size) are discarded from the analysis. The remaining probe-
set expression values are collapsed to Ensembl IDs using collapse-
Rows function (74) from WGCNA R package (v1.70-3) with the 
“MaxMean” method (75). The resulting expression matrix with 
Ensembl IDs (n = 13,570) were used for downstream analysis. The 
correlation between the basal gene expression and insulin sensi-
tivity (M value) was calculated by Spearman’s rank correlation, and 
P values are adjusted for multiple testing using the Benjamini- 
Hochberg method. The genes with significant correlations with 
M values (Padj  <  0.10, n  =  640) were used for gene enrichment 
analysis using an over-representation method with the GO:CC 
database (see the “Gene enrichment analysis” section for details). 
The ontology-gene interaction network (the so-called CNET plot) 
from this analysis using the top five enriched terms ranked by 
gene ratio is shown in Fig. 4D. The color code represents the cor-
relation coefficient (Spearman’s ) between gene expression and 
M values.
PCR analysis
RNA was prepared from human skeletal muscle biopsies and pri-
mary human skeletal muscle cells. Gene expression was determined 
by using Fast SYBR Green Master Mix (Thermo Fisher Scientific) 
and self-designed oligonucleotides (oligonucleotide sequences pro-
vided below) or predesigned TaqMan Gene Expression Assays (Thermo 
Fisher Scientific). SYBR human housekeeping: B2M, GUSB, TBP, 
and RPLO. TaqMan mouse housekeeping genes: B2m and Gapdh; 
human: TBP and B2M. Primer sequences and assay IDs are presented 
in table S6.
Immunoblot analysis
Immunoblot analysis was performed as previously described (21) 
with antibodies against OPA1 (no. 80471) from Cell Signaling 
Technology, total OXPHOS (no. 110411) from Abcam (UK), and 
-actin (no. A5441) from Sigma-Aldrich. Protein abundance was 
normalized to -actin.
Live-cell microscopy and determination 
of mitochondrial ROS
Primary human skeletal muscle cells from men with NGT were 
used for the determination of mitochondrial ROS by live-cell mi-
croscopy. Primary skeletal muscle cells were grown and differenti-
ated as described above. MitoSOX (50 g; M36008, Thermo Fisher 
Scientific) was dissolved in 50 l of pluronic F127 (P6866, Invitro-
gen) and 50 l of dimethyl sulfoxide to make the MitoSOX stock 
solution. MitoSOX stock solution (5 l) was added to the media and 
incubated for 15 min at 37°C and 5% CO2. Thereafter, media from 
the cell dish were removed; the dish was mounted on the confocal 
microscope (Zeiss LSM710) and perfused with Tyrode solution 
(in mM): 121 NaCl, 5 KCl, 1.8 CaCl2, 0.4 NaH2PO4, 0.5 MgCl2, 
24 NaHCO3, 0.1 EDTA, and 5.5 glucose. Cells were then imaged 
with 2-min intervals for 20 min and thereafter switched to Tyrode 
solution supplemented with FCCP (2 M) for 20 min. All images 
were analyzed with ImageJ.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abi9654
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